Skip to main content
Premium Trial:

Request an Annual Quote

Benjamin Salisbury

GenomOncology has appointed Benjamin Salisbury as vice president of new products and marketing. He will be responsible for the company's corporate marketing and for bringing to market new products that build upon the company's precision medicine technology. Salisbury joins the company from Knome, where he guided the transition of the company's research-focused, internal-use software for next-generation sequencing analysis to a product that supports clinical laboratory operations. He has also held several management and scientific positions at Transgenomic, PGxHealth, and Genaissance Pharamaceuticals. As a scientist, Salisbury's expertise includes molecular diagnostics, pharmacogenomics, population genetics, statistical genetics, and algorithm development. He has authored over 30 peer-reviewed publications in these and other fields. 

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.